Mineralys Therapeutics, Inc.
MLYS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001933414
In the last 90 days, Mineralys Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 225 institutions reported holding it in 13F filings for Q2 2026, worth $2.69B in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Mineralys Therapeutics, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 193 | 2 | 223 | +32 |
| Shares | 79.3M | 4.14K | 88.4M | +9.06M (+11.4%) |
| Value | $3.01B | $156.9K | $3.21B | +$199.8M (+6.6%) |
2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (52)
Institutions that held Mineralys Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (20)
Institutions that held Mineralys Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Nearwater Capital Markets, Ltd | 450,000 | $17.1M |
| Tang Capital Management LLC | 200,000 | $7.58M |
| Atika Capital Management LLC | 174,000 | $6.60M |
| Jain Global LLC | 120,854 | $4.58M |
| Adage Capital Partners GP, L.L.C. | 105,000 | $3.98M |
| Hudson Bay Capital Management LP | 75,768 | $2.87M |
| Capstone Investment Advisors, LLC | 42,276 | $1.60M |
| Resolute Capital Asset Partners LLC | 40,000 | $1.52M |
| Jane Street Group, LLC | 37,145 | $1.41M |
| Mark Asset Management LP | 19,465 | $738.1K |
| Balyasny Asset Management LLC | 15,268 | $579.0K |
| Caption Management, LLC | 13,000 | $493.0K |
| Oxford Asset Management LLP | 9,123 | $345.9K |
| Scientech Research LLC | 7,964 | $302.0K |
| ExodusPoint Capital Management, LP | 6,670 | $252.9K |
| Bridgefront Capital, LLC | 6,338 | $240.3K |
| Letko, Brosseau & Associates Inc | 5,475 | $207.6K |
| Quantbot Technologies LP | 39 | $1.48K |
| Rise Advisors, LLC | 37 | $1.40K |
| Federated Hermes, Inc. | 21 | $796 |
Not filed for Q4 2025 yet (2)
Institutions that held Mineralys Therapeutics, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Point72 (DIFC) Ltd | 4,037 | $153.1K |
| FSA Wealth Management LLC | 100 | $3.79K |